The most common gene fusion combines EWS with FLI1,1 which has a rate-limiting role in ES pathogenesis,2 as interference with EWS-FLI1 expression or function results in tumor regression in vivo and dysregulates ES tumor cell growth in vitro. This evidence concerns the gene FLI1 and Ewing sarcoma.